Dr. Russell Scott Berman, MD

Dr. Berman practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Berman's NPI, 1710988506, was assigned on August 3, 2005. Dr. Berman graduated from New York University School of Medicine in 1990. Dr. Berman holds New York license 186818.

Dr. Berman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Berman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Berman to 2 more clinical labs, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berman practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Berman's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Berman is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Berman's licenses on file in 2 states: New York and Texas.

Dmand AI lists cancerous skin growth removal and removal of damaged skin or skin graft among the conditions Dr. Berman treats.

CMS data shows 40 Medicare services from Dr. Berman across 1 procedure code in 2024, all of them office visits, for 50 Medicare patients. Medicare paid $1,687 for them. Every service was in an office.

CMS counts 50 Medicare patients who saw Dr. Berman in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berman's median patient age at 72, with 36% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Berman for performance year 2024, reported through an alternative payment model (APM). Dr. Berman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berman as offering telehealth. CMS counts 12 procedures of melanoma (skin cancer) excision by Dr. Berman, more than 66% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 153 papers to Dr. Berman, published from 2006 to 2025. 2017 was the busiest year, with 13. The most frequent topics are Melanoma, Skin Neoplasms and Curriculum. Dr. Berman has published most often in Ann Surg Oncol. Dr. Berman's most frequent co-authors are Anna C. Pavlick, DO, David Polsky, MD and Hersch Leon Pachter, MD.

CMS Open Payments shows 1 general payment to Dr. Berman from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Iovance Biotherapeutics, Inc. paid the most, $21.

Dmand AI lists 4 awards for Dr. Berman, most recently New York Magazine: Top Doctors in 2022.

Dr. Berman graduated from New York University School of Medicine in 1990. Dr. Berman is a member of AOA, ACS, ASCO, SSAT and SSO.

Dr. Berman is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.